These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 627133)

  • 1. Hemodynamic and respiratory effects of morphine and butorphanol.
    Popio KA; Jackson DH; Ross AM; Schreiner BF; Yu PN
    Clin Pharmacol Ther; 1978 Mar; 23(3):281-7. PubMed ID: 627133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.
    Pircio AW; Gylys JA; Cavanagh RL; Buyniski JP; Bierwagen ME
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):231-57. PubMed ID: 60089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory and circulatory effects of intravenous butorphanol and morphine.
    Nagashima H; Karamanian A; Malovany R; Radnay P; Ang M; Koerner S; Foldes FF
    Clin Pharmacol Ther; 1976 Jun; 19(6):738-45. PubMed ID: 773585
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of butorphanol and morphine as analgesics for coronary bypass surgery: a double-blind, randomized study.
    Aldrete JA; de Campo T; Usubiaga LE; Renck R; Suzuki D; Witt WO
    Anesth Analg; 1983 Jan; 62(1):78-83. PubMed ID: 6600383
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction.
    Lee G; Low RI; Amsterdam EA; DeMaria AN; Huber PW; Mason DT
    Clin Pharmacol Ther; 1981 May; 29(5):576-81. PubMed ID: 7214787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceiling effect for respiratory depression by nalbuphine.
    Romagnoli A; Keats AS
    Clin Pharmacol Ther; 1980 Apr; 27(4):478-85. PubMed ID: 7357806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hemodynamic effects of morphine, butorphanol, buprenorphine and pentazocine on ICU patients.
    Mitaka C; Sakanishi N; Tsunoda Y; Mishima Y
    Bull Tokyo Med Dent Univ; 1985 Jun; 32(2):31-9. PubMed ID: 3864560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy reviews: evaluation of butorphanol tartrate.
    Ameer B; Salter FJ
    Am J Hosp Pharm; 1979 Dec; 36(12):1683-91. PubMed ID: 393109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects and analgesic efficacy of the agonist-antagonist opioids.
    Zola EM; McLeod DC
    Drug Intell Clin Pharm; 1983 Jun; 17(6):411-7. PubMed ID: 6861632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of butorphanol, flunixin, levorphanol, morphine, and xylazine in ponies.
    Kalpravidh M; Lumb WV; Wright M; Heath RB
    Am J Vet Res; 1984 Feb; 45(2):217-23. PubMed ID: 6711945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone, naltrexone, and related noroxymorphones.
    Blumberg H; Dayton HB
    Adv Biochem Psychopharmacol; 1973; 8(0):33-43. PubMed ID: 4794989
    [No Abstract]   [Full Text] [Related]  

  • 12. The animal pharmacology of buprenorphine, an oripavine analgesic agent.
    Cowan A; Doxey JC; Harry EJ
    Br J Pharmacol; 1977 Aug; 60(4):547-54. PubMed ID: 409449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiohemodynamic and respiratory effects of eptazocine, a new analgesic agent, in anesthetized dogs].
    Kimura T; Murakami H; Sakai H; Waki I
    Nihon Yakurigaku Zasshi; 1988 Mar; 91(3):151-61. PubMed ID: 3371799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of 20681-S and 20682-S, 6-oxo-N-cyclopropylmethylmorphinans, as narcotic antagonist analgesics.
    Hirose K; Matsushita A; Kojima Y; Eigyo M; Jyoyama H; Shiomi T; Tsukinoki Y; Hatakeyama H; Matsubara K; Kawasaki K
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):79-91. PubMed ID: 43119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative gastrointestinal and biliary tract effects of morphine and butorphanol (Stadol).
    Roebel LE; Cavanagh RL; Buyniski JP
    J Med; 1979; 10(4):225-38. PubMed ID: 43349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analgesic and respiratory depressant activities of N-allyl noretrophine and morphine in the mouse.
    Bousfield JD; Rees JM
    J Pharm Pharmacol; 1969 Sep; 21(9):630-2. PubMed ID: 4390349
    [No Abstract]   [Full Text] [Related]  

  • 17. The increased efficacy of narcotic antagonists induced by various narcotic analgesics.
    Tulunay FC; Takemori AE
    J Pharmacol Exp Ther; 1974 Sep; 190(3):395-400. PubMed ID: 4416308
    [No Abstract]   [Full Text] [Related]  

  • 18. The respiratory, circulatory, and analgesic effects of naloxone-narcotic mixtures in anaesthetized subjects.
    Foldes FF; Davidson GM; Duncalf D; Kuwabara S; Siker ES
    Can Anaesth Soc J; 1965 Nov; 12(6):608-21. PubMed ID: 5865529
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog.
    Schurig JE; Cavanagh RL; Buyniski JP
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):296-304. PubMed ID: 686916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of butorphanol-oxygen anesthesia in dogs.
    Sederberg J; Stanley TH; Reddy P; Liu WS; Port D; Gillmor S
    Anesth Analg; 1981 Oct; 60(10):715-9. PubMed ID: 7197474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.